Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-069598

Chief Financial Officer acquired 2,896 shares (grant or award)

  • Chief Financial Officer gave up 571 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2024-06-03 Shares withheld for taxes −571 $30.17 $17,227 8,965 D
Mokari Atabak Chief Financial Officer 2024-06-03 Grant or award +1,448 $31.30 $45,322 10,413 D
Mokari Atabak Chief Financial Officer 2024-06-03 Grant or award +1,448 11,861 D
Loading xslF345X05/ownership.xml…